<div><p>Cancers arise from successive rounds of mutation and selection, generating clonal populations that vary in size, mutational content and drug responsiveness. Ascertaining the clonal composition of a tumor is therefore important both for prognosis and therapy. Mutation counts and frequencies resulting from next-generation sequencing (NGS) potentially reflect a tumor's clonal composition; however, deconvolving NGS data to infer a tumor's clonal structure presents a major challenge. We propose a generative model for NGS data derived from multiple subsections of a single tumor, and we describe an expectation-maximization procedure for estimating the clonal genotypes and relative frequencies using this model. We demonstrate, via simulatio...
The sensitivity of massively-parallel sequencing has confirmed that most cancers are oligoclonal, wi...
The extensive genetic heterogeneity of cancers can greatly affect therapy success due to the existen...
SummaryThe extensive genetic heterogeneity of cancers can greatly affect therapy success due to the ...
Cancers arise from successive rounds of mutation and selection, generating clonal populations that v...
Clonal deconvolution of mutational landscapes is crucial to understand the evolutionary dynamics of ...
Traditional classifications and treatment of human cancers have operated with limitations surroundin...
Intra-tumor heterogeneity presents itself through the evolution of subclones during cancer progressi...
Intra-tumor heterogeneity concerns the existence of genetically different subclones within the same ...
Knowledge about the clonal evolution of a tumor can help to interpret the function of its genetic al...
Genomic analysis provides insights into the role of copy number variation in disease, but most metho...
Multistage tumorigenesis is a dynamic process characterized by the accumulation of mutations. Thus, ...
<div><p>Recent improvements in next-generation sequencing of tumor samples and the ability to identi...
Intra-tumor heterogeneity concerns the existence of genetically different subclones within the same ...
Tumor DNA sequencing data can be interpreted by computational methods that analyze genomic heterogen...
Multistage tumorigenesis is a dynamic process characterized by the accumulation of mutations. Thus, ...
The sensitivity of massively-parallel sequencing has confirmed that most cancers are oligoclonal, wi...
The extensive genetic heterogeneity of cancers can greatly affect therapy success due to the existen...
SummaryThe extensive genetic heterogeneity of cancers can greatly affect therapy success due to the ...
Cancers arise from successive rounds of mutation and selection, generating clonal populations that v...
Clonal deconvolution of mutational landscapes is crucial to understand the evolutionary dynamics of ...
Traditional classifications and treatment of human cancers have operated with limitations surroundin...
Intra-tumor heterogeneity presents itself through the evolution of subclones during cancer progressi...
Intra-tumor heterogeneity concerns the existence of genetically different subclones within the same ...
Knowledge about the clonal evolution of a tumor can help to interpret the function of its genetic al...
Genomic analysis provides insights into the role of copy number variation in disease, but most metho...
Multistage tumorigenesis is a dynamic process characterized by the accumulation of mutations. Thus, ...
<div><p>Recent improvements in next-generation sequencing of tumor samples and the ability to identi...
Intra-tumor heterogeneity concerns the existence of genetically different subclones within the same ...
Tumor DNA sequencing data can be interpreted by computational methods that analyze genomic heterogen...
Multistage tumorigenesis is a dynamic process characterized by the accumulation of mutations. Thus, ...
The sensitivity of massively-parallel sequencing has confirmed that most cancers are oligoclonal, wi...
The extensive genetic heterogeneity of cancers can greatly affect therapy success due to the existen...
SummaryThe extensive genetic heterogeneity of cancers can greatly affect therapy success due to the ...